Option Care Health (NASDAQ:OPCH – Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect Option Care Health to announce earnings of $0.4894 per share and revenue of $1.48 billion for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, November 4, 2026 at 12:30 PM ET.
Option Care Health Stock Down 0.4%
Shares of NASDAQ:OPCH opened at $31.69 on Tuesday. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The company’s 50-day moving average price is $26.67 and its two-hundred day moving average price is $26.45. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The firm has a market cap of $4.75 billion, a P/E ratio of 19.80, a P/E/G ratio of 1.90 and a beta of 0.58.
Analysts Set New Price Targets
OPCH has been the subject of a number of research analyst reports. Truist Financial set a $32.05 target price on shares of Option Care Health in a research note on Wednesday, October 7th. Barrington Research cut shares of Option Care Health from an “outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Weiss Ratings raised shares of Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, October 20th. UBS Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $39.00 to $32.05 in a research report on Friday, October 9th. Finally, Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $29.48.
About Option Care Health
Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.
Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.
Read More
- Five stocks we like better than Option Care Health
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
